The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proteogenomic and clinical implications of unique recurrent splice variants in clear cell renal cell carcinoma.
 
Andrew Chang
No Relationships to Disclose
 
Paul Stewart
No Relationships to Disclose
 
Nicholas Haig Chakiryan
No Relationships to Disclose
 
Alex C. Soupir
No Relationships to Disclose
 
Yijun Tian
No Relationships to Disclose
 
Dongliang Du
No Relationships to Disclose
 
Jamie K. Teer
Patents, Royalties, Other Intellectual Property - Patent application: Large Data Set Negative Information Storage Model.
 
Youngchul Kim
No Relationships to Disclose
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Exelixis; Pfizer
 
Yonghong Zhang
No Relationships to Disclose
 
John M Koomen
No Relationships to Disclose
 
Anders E. Berglund
No Relationships to Disclose
 
Liang Wang
No Relationships to Disclose
 
Timothy J. Robinson
No Relationships to Disclose
 
Brandon J. Manley
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - EGFR splice variant as a biomarker in renal cancer (Inst)